Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | KALV KalVista Pharmaceuticals | Common Stock | Buy | Acquire P | Yes | No | 9.22 | 14,562 | 134.26 k | 5,012,796 |
31 Jan 25 | KALV KalVista Pharmaceuticals | Common Stock | Buy | Acquire P | Yes | No | 8.89 | 11,754 | 104.49 k | 4,998,234 |
30 Jan 25 | KALV KalVista Pharmaceuticals | Common Stock | Buy | Acquire P | Yes | No | 8.76 | 43,707 | 382.87 k | 4,986,480 |
5 Jun 24 | APGE Apogee Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 43.85 | 10,370 | 454.72 k | 10,370 |
20 Feb 24 | KALV KalVista Pharmaceuticals | Pre-Funded Warrants Common Stock | Buy | Acquire P | Yes | No | 15.249 | 655,738 | 10.00 mm | 655,738 |
8 Feb 24 | KALV KalVista Pharmaceuticals | Common Stock | Buy | Acquire P | Yes | No | 14.7 | 29,747 | 437.28 k | 4,824,731 |
7 Feb 24 | KALV KalVista Pharmaceuticals | Common Stock | Buy | Acquire P | Yes | No | 14.56 | 51,827 | 754.60 k | 4,794,984 |
6 Feb 24 | KALV KalVista Pharmaceuticals | Common Stock | Buy | Acquire P | Yes | No | 14.74 | 4,474 | 65.95 k | 4,743,157 |